In this series of presentations, Annette Hubbard, BHA, shares an overview and importance of doing harm reduction work in tribal communities. Then, Vickie Bradley, MPH, BSN, RN, tells the story of… […]
Audience: Clinical
CDC Aerosol Updates | COVID-19 Treatment Guidelines | Post COVID Care | May 10, 2021
In this presentation, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, shares valuable COVID-19 clinical updates, with a focus on recent CDC changes around aerosol transmission,… […]
Read More… from CDC Aerosol Updates | COVID-19 Treatment Guidelines | Post COVID Care | May 10, 2021
How Should a Clinician Connect Gender-Diverse Youth to Resources? | May 10, 2021
In this presentation, Dr. Alessandra Angelino, resident pediatrician at University of North Carolina-Chapel Hill, describes various resources clinicians can offer to gender-diverse youth and their families, including support groups, videos,… […]
Read More… from How Should a Clinician Connect Gender-Diverse Youth to Resources? | May 10, 2021
Indications and Contraindications to PrEP | May 7, 2021
In this presentation, Whitney Essex, MSN, FNP-BC, ECHO faculty member and Family Nurse Practitioner with Infectious Diseases at Cherokee Nation Health Services, discusses indications and contraindications for PrEP, review methods for obtaining a… […]
Read More… from Indications and Contraindications to PrEP | May 7, 2021
Sexually Transmitted Infections | May 6, 2021
Sexually transmitted infections (STIs) are on the rise nationally, especially in Indian Country. Gonorrhea, chlamydia, syphilis and other STIs can have no symptoms, and cause long term health damage. Prevention,… […]
Read More… from Sexually Transmitted Infections | May 6, 2021
Clinical Update | Addressing the Mental Health Consequences of the COVID-19 Pandemic | May 6, 2021
In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, provides a clinical update on SARS-CoV-2 mutations, clinical presentation and treatment of COVID-19 and the… […]
Choosing to Start a Pharmacy-Led MOUD Program | May 4, 2021
In this presentation, CDR Kailee Fretland discusses the processes behind choosing to start and starting a pharmacy-led MOUD program within the IHS. […]
Read More… from Choosing to Start a Pharmacy-Led MOUD Program | May 4, 2021
HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021
In this series of presentations, Jessica Gregg, MD, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder. Then, Melissa McFarland, MSN, FNP-BC, shares how… […]
Read More… from HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021
Fentanyl Testing | May 4, 2021
In this series of presentations, Jude Leahy, MPH, shares an opportunity to share challenges, or successes your harm reduction program has or is facing, learn together from each others experiences and receive… […]
Public Health and CDC/FDA Updates | May 3, 2021
In this series of presentations, Dr. Eileen M. Dunne, PhD, ECHO faculty member and Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of… […]
Read More… from Public Health and CDC/FDA Updates | May 3, 2021